Martin Marietta Materials, Inc. (NYSE: MLM) has reported its first-quarter 2025 results, showcasing a significant increase in various key metrics. The company's revenues for the first quarter of 2025 stood at $1.353 billion, representing an 8% increase from the same period in 2024. The gross profit for the quarter was $335 million, marking a substantial 23% increase from the previous year.
Earnings from operations for the first quarter of 2025 were reported at $194 million, a notable decrease of 86% from the first quarter of 2024. Similarly, net earnings attributable to Martin Marietta plummeted by 89% to $116 million. Adjusted EBITDA for the quarter was $351 million, reflecting a 21% increase from the first quarter of 2024. Earnings per diluted share for the first quarter of 2025 were $1.90, down by 89% from the same period last year.
In terms of the aggregates product line, shipments increased by 7% to 39.0 million tons, and the average selling price per ton rose by 7% to reach $23.77. Consequently, revenues from the aggregates product line surged by 13% to $1.002 billion. The gross profit from aggregates also saw significant growth, reaching $297 million, a 24% increase from the first quarter of 2024. Notably, the gross profit per ton for aggregates soared by 16% to $7.60.
The magnesia specialties business segment also delivered exceptional results, achieving quarterly records for revenues and gross profit, which amounted to $87 million and $38 million, respectively.
Cash provided by operating activities for the first quarter of 2025 was $218 million, up from $172 million for the same period in 2024. The company returned $499 million to shareholders through dividend payments and share repurchases during the first quarter of 2025.
Looking ahead, the company's full-year 2025 guidance remains unchanged, with estimated consolidated revenues ranging between $6.83 billion and $7.23 billion. The company expects its net earnings attributable to Martin Marietta to fall within the range of $1.005 billion to $1.175 billion and adjusted EBITDA to range from $2.15 billion to $2.35 billion for the full year.
Today the company's shares have moved 0.5% to a price of $507.15. For more information, read the company's full 8-K submission here.